Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Infinity Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (41)	7/3/2006 2:43:22 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 210

See the Keryx and Kosan threads for glowing reviews of their drugs for MM. Anderson sits on the SAB of Infinity. ipi.com It would be very interesting to listen in on one of their meetings. So many drugs, so many companies--but after all that competition, even if you only made $10k a patient times 10k MM Patients, gosh, that is real money for a drug that works. And more for a drug that can be used for other cancers as well.